Insider Transactions in Q4 2021 at Biolife Solutions Inc (BLFS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
517
-0.67%
|
$20,163
$39.37 P/Share
|
|
Dec 29
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
705
-0.68%
|
$27,495
$39.37 P/Share
|
|
Dec 29
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
928
-0.36%
|
$36,192
$39.37 P/Share
|
|
Dec 29
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
625
-0.89%
|
$24,375
$39.37 P/Share
|
|
Dec 29
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
736
-0.36%
|
$28,704
$39.37 P/Share
|
|
Dec 22
2021
|
Troy Wichterman Chief Financial Officer |
BUY
Open market or private sale
|
Direct |
310
+1.38%
|
$11,780
$38.49 P/Share
|
|
Dec 15
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
16,666
-6.02%
|
$533,312
$32.8 P/Share
|
|
Dec 15
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+5.67%
|
$16,666
$1.78 P/Share
|
|
Dec 13
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
16,666
-6.02%
|
$549,978
$33.82 P/Share
|
|
Dec 13
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+5.67%
|
$16,666
$1.78 P/Share
|
|
Dec 09
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,464
-4.22%
|
$401,240
$35.15 P/Share
|
|
Dec 09
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,464
+4.05%
|
$11,464
$1.64 P/Share
|
|
Dec 08
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,853
-4.11%
|
$318,708
$36.49 P/Share
|
|
Dec 08
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,853
+3.94%
|
$8,853
$1.64 P/Share
|
|
Dec 07
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.22%
|
$412,596
$36.52 P/Share
|
|
Dec 07
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+4.05%
|
$11,461
$1.64 P/Share
|
|
Dec 07
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
10,000
-11.41%
|
$360,000
$36.52 P/Share
|
|
Dec 07
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+10.24%
|
$20,000
$2.62 P/Share
|
|
Dec 06
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.61%
|
$340,000
$34.39 P/Share
|
|
Dec 06
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.41%
|
$10,000
$1.64 P/Share
|
|
Nov 30
2021
|
Troy Wichterman Chief Financial Officer |
BUY
Open market or private sale
|
Direct |
33
+0.15%
|
$1,221
$37.59 P/Share
|
|
Nov 30
2021
|
Michael Rice |
BUY
Open market or private sale
|
Direct |
957
+0.37%
|
$35,409
$37.59 P/Share
|
|
Nov 30
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Open market or private sale
|
Direct |
448
+0.22%
|
$16,576
$37.59 P/Share
|
|
Nov 30
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
315
-0.45%
|
$11,655
$37.59 P/Share
|
|
Nov 22
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,332
-18.75%
|
$751,272
$46.19 P/Share
|
|
Nov 22
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,332
+15.79%
|
$16,332
$1.64 P/Share
|
|
Nov 18
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
7,000
-6.34%
|
$350,000
$50.75 P/Share
|
|
Nov 17
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
7,000
-5.97%
|
$357,000
$51.08 P/Share
|
|
Nov 17
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.6%
|
$510,000
$51.07 P/Share
|
|
Nov 17
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.4%
|
$10,000
$1.64 P/Share
|
|
Nov 16
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
7,000
-5.63%
|
$357,000
$51.39 P/Share
|
|
Nov 16
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.35%
|
$308,000
$50.63 P/Share
|
|
Nov 16
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.85%
|
$6,160
$1.64 P/Share
|
|
Nov 15
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.35%
|
$289,520
$47.96 P/Share
|
|
Nov 15
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.85%
|
$6,160
$1.64 P/Share
|
|
Nov 15
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.6%
|
$480,000
$48.11 P/Share
|
|
Nov 15
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.4%
|
$10,000
$1.64 P/Share
|
|
Nov 09
2021
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
1,750
-5.68%
|
$92,750
$53.0 P/Share
|
|
Nov 04
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.2%
|
$641,816
$56.81 P/Share
|
|
Nov 04
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+4.03%
|
$11,461
$1.64 P/Share
|
|
Nov 02
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.2%
|
$618,894
$54.72 P/Share
|
|
Nov 02
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+4.03%
|
$11,461
$1.64 P/Share
|
|
Oct 25
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,332
-18.75%
|
$718,608
$44.45 P/Share
|
|
Oct 25
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,332
+15.79%
|
$16,332
$1.64 P/Share
|
|
Oct 25
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
2,371
-1.87%
|
$104,324
$44.62 P/Share
|
|
Oct 20
2021
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
272
-1.37%
|
$11,424
$42.34 P/Share
|
|
Oct 20
2021
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
399
-1.28%
|
$16,758
$42.34 P/Share
|
|
Oct 20
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.6%
|
$410,000
$41.97 P/Share
|
|
Oct 20
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.4%
|
$10,000
$1.64 P/Share
|
|
Oct 18
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.6%
|
$410,000
$41.34 P/Share
|